Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis

Emerging data have suggested that circulating tumor DNA (ctDNA) can be a reliable biomarker for minimal residual disease (MRD) in CRC patients. Recent studies have shown that the ability to detect MRD using ctDNA assay after curative-intent surgery will change how to assess the recurrence risk and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Chidharla, Anusha, Rapoport, Eliot, Agarwal, Kriti, Madala, Samragnyi, Linares, Brenda, Sun, Weijing, Chakrabarti, Sakti, Kasi, Anup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298915/
https://www.ncbi.nlm.nih.gov/pubmed/37373376
http://dx.doi.org/10.3390/ijms241210230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298915/
https://www.ncbi.nlm.nih.gov/pubmed/37373376
http://dx.doi.org/10.3390/ijms241210230

Ejemplares similares